drugset / Trial / NCT04529187

Effect of Midazolam and Dexmedetomidine on Heart Function - A Randomized MRI-based Study.

NCT04529187 ↗

Phase 4 Completed 30 enrolled Masaryk Hospital Krajská zdravotní a.s.
RandomizedParallel-groupOpen-labelSupportive care

Summary

To compare the changes in heart function, induced after sedation with midazolam or dexmedetomidine, using cardiac magnetic resonance imaging (MRI). This study is a randomized unmasked study, in which participant will be allocated by the envelop method into the dexmedetomidine (DEX) group or into the midazolam (MID) group.

Timeline

Start
2018-01-01
Primary completion
2019-12-31
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.7 ug/kg —
Comparator Midazolam Small molecule 2 mg Intravenous

Indications

No indication recorded.